Related Experiment Video
Updated: Jun 12, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Cardiovascular Disease Mortality Trends, 2010-2022: An Update with Final Data
Rebecca C Woodruff1, Xin Tong1, Fleetwood V Loustalot1
1Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Chamblee, Georgia.
Cardiovascular disease mortality rates declined in 2022 after pandemic increases, but remain elevated. Continued focus on cardiovascular disease prevention, detection, and management is crucial.
Area of Science:
- Public Health
- Epidemiology
- Cardiovascular Medicine
Background:
- Age-adjusted mortality rates (AAMR) for cardiovascular diseases (CVD) rose significantly in 2020 and 2021.
- Provisional data suggested a continued increase in 2022, indicating substantial excess CVD deaths during the COVID-19 pandemic.
Purpose of the Study:
- To provide updated estimates of CVD AAMR and excess deaths using final data for 2022.
- To analyze trends in CVD mortality among U.S. adults aged 35 years and older from 2010 to 2022.
Main Methods:
- Analysis of final Multiple Cause of Death files from the National Vital Statistics System (2010-2022).
- Calculation of age-adjusted mortality rates (AAMR) for CVD as the underlying cause of death.
- Estimation of excess CVD deaths from 2020 to 2022 for U.S. adults aged ≥35 years.
Main Results:
- The CVD AAMR in 2022 was 434.6 deaths per 100,000, a decrease from 2021 (451.8) but similar to 2012 levels.
- Provisional 2022 data overestimated the final AAMR by 4.6%.
- An estimated 190,661 excess CVD deaths occurred between 2020 and 2022.
Conclusions:
- The CVD AAMR among U.S. adults aged ≥35 years declined in 2022, reversing the adverse trend observed during the COVID-19 pandemic.
- Despite the recent decline, 2022 CVD mortality rates remain higher than pre-pandemic levels.
- There is an ongoing necessity for robust cardiovascular disease prevention, detection, and management strategies.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Medical Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction

